Author/Authors :
Adeleye, Adetayo Division of Respiratory Medicine - Alberta Children’s Hospital, Shaganappi Trail NW, Calgary, Canada , Ho, Alice Division of Neurology - Alberta Children’s Hospital, Shaganappi Trail NW, Calgary, Canada , Aettel-Aguirre, Alberto Department of Pediatrics and Community Health Sciences -University of Calgary - Alberta Children’s Hospital Research Institute for Child and Maternal Health, Canada , Buchhalter, Jeffrey Division of Neurology - Alberta Children’s Hospital, Shaganappi Trail NW, Calgary, Canada , Kirk, Valerie Division of Respiratory Medicine - Alberta Children’s Hospital, Shaganappi Trail NW, Calgary, Canada
Abstract :
Study Objectives. We identified the associated conditions of patients less than 12 months of age who were referred for
polysomnogram (PSG) studies. We collated PSG findings and physician interpretation. We determined the correlation between the
recommended treatment by the PSG interpreting physician and actual prescribed treatment by the referring or subjects’ physician.
We determined adherence with noninvasive positive airway pressure (PAP) treatment. Methods. This was a retrospective cohort
study. Participants included children less than 12 months of age referred for PSG studies between 2007 and 2012. Results. 92 patients
under the age of 12 months were included in the study analysis. Mean (standard deviation, SD) age in days at time of the PSG
study was 208.5 (101.2). 35 (38%) patients had a diagnosis of Trisomy 21. Seven (8%) patients had no prior diagnosis. Median (Q1,
Q3) apnea hypopnea index (AHI) was 22.5 (11.3–37.0). Agreement between the PSG interpreting physician’s recommendation and
actual prescribed treatment by the referring or subjects’ physician was 85.9% [95% CI 77.1–91.6]. Mean (SD) percentage days with
PAP therapy usage more than 4 hours was 25.2% (32). Conclusions. In our experience, despite consistent physician messaging to
families, adherence with noninvasive PAP treatment is low.
